Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii
暂无分享,去创建一个
[1] A. Sher,et al. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. , 1996, Journal of immunology.
[2] Y. Suzuki,et al. IL-4 is protective against development of toxoplasmic encephalitis. , 1996, Journal of immunology.
[3] D. Carvajal,et al. IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .
[4] V. Poli,et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans , 1996, The Journal of experimental medicine.
[5] C. Bogdan,et al. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase , 1996, The Journal of experimental medicine.
[6] R. Gazzinelli,et al. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. , 1996, Journal of immunology.
[7] I. Khan,et al. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. , 1996, Journal of immunology.
[8] E. Unanue,et al. Listeria monocytogenes induces apoptosis of infected hepatocytes. , 1996, Journal of immunology.
[9] S. James. Role of nitric oxide in parasitic infections. , 1995, Microbiological reviews.
[10] C. Hunter,et al. The role of IL12 in toxoplasmosis. , 1995, Research in immunology.
[11] S. Holland,et al. The p47phox mouse knock-out model of chronic granulomatous disease , 1995, Journal of Experimental Medicine.
[12] I. Charles,et al. Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.
[13] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[14] Johnson Ll,et al. Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii infection. , 1995 .
[15] G. Trinchieri,et al. Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice , 1995, European journal of immunology.
[16] M. Burdick,et al. Interferon gamma modulates the expression of neutrophil-derived chemokines. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[17] F. Cunha,et al. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro , 1994, Infection and immunity.
[18] Carl Nathan,et al. Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.
[19] A. Sher,et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. , 1994, Journal of immunology.
[20] J. Heesemann,et al. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion , 1994, Infection and immunity.
[21] C. Hunter,et al. Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates , 1994, Infection and immunity.
[22] I. Khan,et al. Interleukin-12 enhances murine survival against acute toxoplasmosis , 1994, Infection and immunity.
[23] M. Washington,et al. Nitric oxide produced during murine listeriosis is protective , 1994, Infection and immunity.
[24] E. Unanue,et al. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice , 1993, Infection and immunity.
[25] A. Sher,et al. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice , 1993, The Journal of experimental medicine.
[26] A. Sher,et al. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. , 1993, Journal of immunology.
[27] A. Martella,et al. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. , 1993, Clinical immunology and immunopathology.
[28] A. Bradley,et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.
[29] E. Unanue,et al. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. , 1993, Journal of immunology.
[30] A. Sher,et al. The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β , 1992, European journal of immunology.
[31] A. Sher,et al. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.
[32] M. Fresno,et al. Synergism between tumor necrosis factor‐α and interferon‐γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide‐dependent mechanism , 1992 .
[33] L. Fransen,et al. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. , 1992, Journal of immunology.
[34] J. Woodman,et al. Human endothelial cells are activated by IFN-gamma to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. , 1991, Journal of immunology.
[35] J. W. Conlan,et al. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium , 1991, The Journal of experimental medicine.
[36] D. Longo,et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. , 1991, Journal of immunology.
[37] Y. Buchmüller‐Rouiller,et al. Journal of Leukocyte Biology 49:73-82 (1991) Killing of Leishmania Parasites in Activated Murine Macrophages is Based on an L-Arginine-Dependent Process That Produces Nitrogen Derivatives , 2022 .
[38] F. Liew,et al. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. , 1990, Journal of immunology.
[39] Y. Suzuki,et al. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon , 1990, Infection and Immunity.
[40] S. Moncada,et al. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. , 1990, Journal of immunology.
[41] J. Hibbs,et al. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. , 1990, Journal of immunology.
[42] J. Schwartzman,et al. Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts , 1990, Infection and immunity.
[43] M. Meltzer,et al. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. , 1990, Journal of immunology.
[44] S. James,et al. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. , 1989, Journal of immunology.
[45] Y. Suzuki,et al. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. , 1989, Journal of immunology.
[46] H. R. Chang,et al. Macrophage oxidative metabolism and intracellular Toxoplasma gondii. , 1989, Microbial pathogenesis.
[47] H. Murray,et al. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages , 1989, Infection and immunity.
[48] R. Coffman,et al. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. , 1988, Journal of Immunology.
[49] R. Schreiber,et al. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. , 1988, Science.
[50] T. Mosmann,et al. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies , 1987, The Journal of experimental medicine.
[51] C. Black,et al. Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages , 1987, Infection and immunity.
[52] R. Werk. How does Toxoplasma gondii enter host cells? , 1985, Reviews of infectious diseases.
[53] H. Murray,et al. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. , 1985, Journal of immunology.
[54] B. Luft,et al. Effect of murine interferon gamma on murine toxoplasmosis. , 1984, The Journal of infectious diseases.
[55] C. Czuprynski,et al. Killing of Listeria monocytogenes by Inflammatory Neutrophils and Mononuclear Phagocytes From Immune and Nonimmune Mice , 1984, Journal of leukocyte biology.
[56] E. Pfefferkorn. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[57] C. Nathan,et al. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.
[58] S. Tannenbaum,et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.
[59] T. Khavkin. Histological and ultrastructural studies of the interaction of Toxoplasma gondii Tachyzoites with mouse omentum in experimental infection. , 1981, The Journal of protozoology.
[60] V. Tsai,et al. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens , 1980, The Journal of experimental medicine.
[61] C. Wilson,et al. Activity of human blood leukocytes against Toxoplasma gondii. , 1979, The Journal of infectious diseases.
[62] H. Murray,et al. Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates , 1979, The Journal of experimental medicine.
[63] C. Nathan,et al. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates , 1979, The Journal of experimental medicine.
[64] R. McLeod,et al. A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen. , 1979, Journal of immunological methods.
[65] E. Sadun,et al. Immunology of Parasitic Infections , 1977 .
[66] E. Pfefferkorn,et al. Specific labeling of intracellular Toxoplasma gondii with uracil. , 1977, The Journal of protozoology.
[67] J. Remington,et al. A Role for Activated Macrophages in Resistance to Infection with Toxoplasma , 1972, Infection and immunity.
[68] A. Sher,et al. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.
[69] D. Carvajal,et al. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. , 1996, Immunity.
[70] L. Johnson,et al. Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii infection. , 1995, Natural immunity.